特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

COVID-19診断の世界市場

COVID-19 Diagnostics: Global Markets

発行 BCC Research 商品コード 950329
出版日 ページ情報 英文 186 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
COVID-19診断の世界市場 COVID-19 Diagnostics: Global Markets
出版日: 2020年07月15日 ページ情報: 英文 186 Pages
概要

世界のCOVID-19診断市場は、2020年に603億米ドルとなる見通しです。同市場は、2021年から2027年までの間に15%のCAGRで成長する見通しで、2021年の844億米ドルから2027年には1,951億米ドルに達すると予測されています。 また、COVID-19ベースの分子検査は14.8%のCAGR、血清検査は15.2%のCAGRで成長すると見込まれています。(予測期間:共に2021年~2027年)

当レポートは、世界のCOVID-19診断市場について調査しており、市場規模や予測、動向、成長および抑制要因、タイプ・技術・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 結論・ハイライト

第3章 市場と技術の背景

  • パンデミック発生の概要
  • 発生の歴史
  • COVID-19の症状
  • COVID-19の進展
  • 潜伏期間
  • 疫学
  • 過去から学んだ教訓

第4章 COVID-19とR&Dの取り組み

  • COVID-19医薬品開発の潜在的なターゲット
    • Basigin (CD147)
    • C-C Chemokine Receptor Type 5 (CCR5)
    • Envelope Protein (E) (SARS-CoV-2; COVID-19)
    • Epithelial Sodium Channel (ENaC)
    • Histamine N-Methyltransferase (HMT)
    • Interleukin-6 Receptor Subunit α (IL-6RA)
    • Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
    • Nucleocapsid (N) (SARS-CoV-2; COVID-19)
  • COVID-19の研究開発
  • 人工呼吸器の再発明の必要性
  • COVID-19臨床試験情勢

第5章 COVID-19の経済的影響

  • コロナウイルスが世界の経済に与える影響
  • COVID-19に関する政府支出
  • 世界の経済の予測
  • COVID-19の社会的影響

第6章 COVID-19のヘルスケア産業への影響

  • COVID-19の製薬サプライチェーンへの影響
  • 臨床試験の中断
  • 保険プロバイダーへの影響
  • 健康技術評価への影響
  • ヘルスケア買収への脅威

第7章 市場力学

  • 市場成長要因
    • 概観
    • COVID 19症例の増加
    • COVID-19検査キットおよびワクチンの研究開発を支援する政府および民間基金
    • 診断キットとデバイスの緊急使用許可(EUA)の増加
    • 老年人口の増加
    • 非医療機器/診断会社による主な発展とサポート
  • 市場抑制要因
    • 診断キットの輸出制限
    • テスト結果の精度
  • 市場機会
    • 迅速、正確、手頃な検査の開発
    • 戦略的研究開発イニシアチブ

第8章 市場の内訳:タイプ別

  • 世界市場
  • 分子検査
  • 血清学検査

第9章 市場の内訳:技術別

  • 世界市場
  • RT-PCR
  • 等温増幅
  • CRISPR
  • ELISA
  • ハイブリダイゼーション
  • その他

第10章 市場の内訳:エンドユーザー別

  • 世界市場
  • 病院
  • 公衆衛生研究所
  • 民間研究所
  • その他

第11章 市場の内訳:地域別

  • 世界市場
  • 欧州
  • 北米
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ

第12章 COVID-19診断業界の規制構造

  • コロナウイルス治療加速プログラム(CTAP)
  • COVID-19パンデミック中に実施されている臨床試験
  • 医薬品不足への対応
  • COVID-19パンデミック中の継続的な臨床試験のための国家規制当局

第13章 競合情勢

  • 世界の企業ランキング分析
  • COVID 19診断の世界の市場への洞察
  • 競合
  • 合併と買収
  • 契約、契約、提携、協業
  • 新製品承認

第14章 企業プロファイル

  • 主要な診断メーカー
    • ABBOTT
    • BECTON, DICKINSON AND CO.
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES INC.
    • DANAHER CORP.
    • F. HOFFMANN-LA ROCHE LTD.
    • GENMARK DIAGNOSTICS INC.
    • HOLOGIC INC.
    • QIAGEN NV
    • SIEMENS HEALTHCARE AG
    • THERMO FISHER SCIENTIFIC INC.
  • その他の企業
    • 1DROP DIAGNOSTICS
    • CEPHEID
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • PERKINELMER INC.
    • QUEST DIAGNOSTICS
    • VEREDUS LABORATORIES

第15章 付録:略語

図表

List of Tables

  • Summary Table B: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
  • Summary Table A: Global Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 1: COVID-19 Symptoms, by Percentage of Patients
    • Table 2: COVID-19 CFR, by Region, as of March 2020
    • Table 3: COVID-19 CFR, by Selected Countries, as of March 2020
    • Table 4: COVID-19 Confirmed Cases and Deaths, by Country, as of April 15, 2020
    • Table 5: COVID-19 Cases and Deaths per 1 Million Population, by Selected Country
    • Table 6: Total Number of Diagnostic Tests Performed per 1 Million Population, by Selected Country
    • Table 7: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
    • Table 8: COVID-19 Therapeutics in Development, by Biopharmaceutical Company
    • Table 9: COVID-19 Vaccines in Development, by Biopharmaceutical Companies in Collaboration
    • Table 10: COVID-19 Vaccines in Development, by Biopharmaceutical Company
    • Table 11: Modifiable Breathing Devices Eligible for Emergency Use Authorization (EUA), by Company
    • Table 12: Clinical Trials on COVID-19, by Phase
    • Table 13: Clinical Trials on COVID-19, by Intervention
    • Table 14: Clinical Trials on COVID-19, by Country
    • Table 15: Interim Economic Outlook Forecasts, by Country/Region, as of March 2, 2020
    • Table 16: Expenditures on COVID-19 Crisis
    • Table 17: Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
    • Table 18: Selected Pending Acquisitions in the Healthcare Industry
    • Table 19: Global COVID 19 Virus Scenario, as of May 20, 2020
    • Table 20: Test Kit Manufacturers and EUA Authorizations
    • Table 21: Global Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 22: U.S. FDA Revised Policy for COVID-19 Molecular Tests During the Public Health Emergency, by Company
    • Table 23: Global Market for COVID-19 Molecular Tests, by Region, Through 2027
    • Table 24: U.S. FDA Revised Policy for COVID-19 Serological Tests During the Public Health Emergency, by Company
    • Table 25: Global Market for COVID-19 Serological Tests, by Region, Through 2027
    • Table 26: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
    • Table 27: Global Market for COVID-19 RT-PCR Diagnostics, by Region, Through 2027
    • Table 28: U.S. FDA Revised Policy for COVID-19 During the Public Health Emergency: Usage of Isothermal Amplification Technology, by Company
    • Table 29: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, Through 2027
    • Table 30: Global Market for COVID-19 CRISPR Diagnostics, by Region, Through 2027
    • Table 31: U.S. FDA Revised Policy for COVID-19 during Public Health Emergency: Usage of ELISA, by Company
    • Table 32: Global Market for COVID-19 ELISA Diagnostics, by Region, Through 2027
    • Table 33: Global Market for COVID-19 Hybridization Diagnostics, by Region, Through 2027
    • Table 34: Global Market for Other Types of COVID-19 Diagnostics, by Region, Through 2027
    • Table 35: Global Market for COVID-19 Diagnostics, by End User, Through 2027
    • Table 36: Global Market for COVID-19 Diagnostics in Hospitals, by Region, Through 2027
    • Table 37: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, Through 2027
    • Table 38: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, Through 2027
    • Table 39: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, Through 2027
    • Table 40: Global Market for COVID-19 Diagnostics, by Region, Through 2027
    • Table 41: European Market for COVID-19 Diagnostics, by Sub-region, Through 2027
    • Table 42: European Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 43: Western European Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 44: North American Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 45: North American Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 46: Asia-Pacific Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 47: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2027
    • Table 48: Latin American Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 49: Middle Eastern and African Market for COVID-19 Diagnostics, by Type, Through 2027
    • Table 50: Global Company Ranking within the Market for COVID-19 Diagnostics, 2020
    • Table 51: Competitors in the Market for COVID-19 Diagnostics
    • Table 52: Recent Acquisitions by Players in the Market for COVID-19 Diagnostics, 2016 and 2017
    • Table 53: Recent Contracts in the Market for COVID-19 Diagnostics, 2020
    • Table 54: Recent Product Approvals on COVID-19 Diagnostics, 2020
    • Table 55: Abbott: Financials, 2016-2019
    • Table 56: Abbott: Product Portfolio, by Business Segment
    • Table 57: Abbott: Rhythm Management Products, 2018
    • Table 58: Abbott: Recent Developments, April 2015-April 2020
    • Table 59: Becton, Dickinson and Co.: Financials, 2019
    • Table 60: Becton, Dickinson and Co.: Product Portfolio
    • Table 61: Becton, Dickinson and Co.: Bioscience Cell Culture Product Portfolio
    • Table 62: Becton, Dickinson and Co.: Recent Developments, August 2015-April 2020
    • Table 63: BioMerieux SA: Financials, 2018
    • Table 64: BioMerieux SA: Products and Services
    • Table 65: BioMerieux SA: Recent Developments, November 2018-March 2020
    • Table 66: Bio-Rad Laboratories Inc.: Financials, 2019
    • Table 67: Bio-Rad Laboratories Inc.: Products and Services
    • Table 68: Bio-Rad Laboratories Inc.: Recent Developments, January 2018-May 2020
    • Table 69: Danaher Corp.: Product Portfolio
    • Table 70: Danaher Corp.: Financials, 2019
    • Table 71: Danaher Corp.: Products and Services
    • Table 72: Danaher Corp.: Recent Developments, August 2015-March 2020
    • Table 73: F. Hoffmann-La Roche Ltd.: Financials, 2019
    • Table 74: F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
    • Table 75: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
    • Table 76: F. Hoffmann-La Roche Ltd.: Product Portfolio
    • Table 77: F. Hoffmann-La Roche Ltd.: Diagnostics Patient Monitoring Product Portfolio
    • Table 78: F. Hoffmann-La Roche Ltd.: Recent Developments, January 2015-April 2020
    • Table 79: GenMark Diagnostics Inc.: Key Products
    • Table 80: GenMark Diagnostics Inc.: COVID Diagnostic Product
    • Table 81: Glenmark Diagnostics Inc.: Financials, 2019
    • Table 82: Glenmark Diagnostics Inc.: Recent Developments, March 2020
    • Table 83: Hologic Inc.: Financials, 2019
    • Table 84: Hologic Inc.: Recent Developments and Strategies, March 2017-March 2020
    • Table 85: Qiagen NV: Financials, 2016 and 2017
    • Table 86: Qiagen NV: Products and Services
    • Table 87: Siemens Healthcare AG: Key Products
    • Table 88: Siemens Healthcare AG: Product Segments
    • Table 89: Siemens Healthcare AG: Financials, 2019
    • Table 90: Siemens Healthcare AG: Recent Developments, March 2016-March 2020
    • Table 91: Thermo Fisher Scientific Inc.: Financials, 2018-2019
    • Table 92: Thermo Fisher Scientific Inc.: Products and Services
    • Table 93: Acronyms Used in This Report

List of Figures

  • Summary Figure A: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
  • Summary Figure B: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
    • Figure 1: Infographic Comparison of the CFRs of the Three Major Beta Coronaviruses: MERS, SARS and COVID-19
    • Figure 2: Distribution of Clinical Trials on COVID-19, by Phase
    • Figure 3: Distribution of Clinical Trials on COVID-19, by Intervention
    • Figure 4: Distribution of Clinical Trials on COVID-19, by Country
    • Figure 5: Comparison of GDP Growth Globally, 2019 vs. 2020
    • Figure 6: Global Healthcare Performance, by Financial Times Stock Exchange (FTSE)
    • Figure 7: Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
    • Figure 8: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 9: Global Market for COVID-19 Molecular Tests, 2020-2027
    • Figure 10: Global Market for COVID-19 Molecular Tests, by Region, 2020-2027
    • Figure 11: Global Market for COVID-19 Serological Tests, 2020-2027
    • Figure 12: Global Market for COVID-19 Serological Tests, by Region, 2020-2027
    • Figure 13: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
    • Figure 14: Global Market for COVID-19 RT-PCR Diagnostics, 2020-2027
    • Figure 15: Global Market for COVID-19 RT-PCR Diagnostics, by Region, 2020-2027
    • Figure 16: Global Market for COVID-19 Isothermal Amplification Diagnostics, 2020-2027
    • Figure 17: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, 2020-2027
    • Figure 18: Global Market for COVID-19 CRISPR Diagnostics, 2020-2027
    • Figure 19: Global Market for COVID-19 CRISPR Diagnostics, by Region, 2020-2027
    • Figure 20: Global Market for COVID-19 ELISA Diagnostics, 2020-2027
    • Figure 21: Global Market for COVID-19 ELISA Diagnostics, by Region, 2020-2027
    • Figure 22: Global Market for COVID-19 Hybridization Diagnostics, 2020-2027
    • Figure 23: Global Market for COVID-19 Hybridization Diagnostics, by Region, 2020-2027
    • Figure 24: Global Market for Other Types of COVID-19 Diagnostics, 2020-2027
    • Figure 25: Global Market for Other Types of COVID-19 Diagnostics, by Region, 2020-2027
    • Figure 26: Global Market Shares of COVID-19 Diagnostics, by End User, 2020
    • Figure 27: Global Market for COVID-19 Diagnostics in Hospitals, 2020-2027
    • Figure 28: Global Market for COVID-19 Diagnostics in Hospitals, by Region, 2020-2027
    • Figure 29: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
    • Figure 30: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, 2020-2027
    • Figure 31: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
    • Figure 32: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, 2020-2027
    • Figure 33: Global Market for COVID-19 Diagnostics in the Other End-User Segment, 2020-2027
    • Figure 34: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, 2020-2027
    • Figure 35: Global Market Shares of COVID-19 Diagnostics, by Region, 2020
    • Figure 36: European Market Shares of COVID-19 Diagnostics, by Sub-region, 2020
    • Figure 37: European Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 38: Western European Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 39: U.K. Market for COVID-19 Diagnostics, 2020-2027
    • Figure 40: Spanish Market for COVID-19 Diagnostics, 2020-2027
    • Figure 41: German Market for COVID-19 Diagnostics, 2020-2027
    • Figure 42: Italian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 43: French Market for COVID-19 Diagnostics, 2020-2027
    • Figure 44: Rest of Western European Market for COVID-19 Diagnostics, 2020-2027
    • Figure 45: Eastern European Market for COVID-19 Diagnostics, 2020-2027
    • Figure 46: North American Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 47: North American Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 48: U.S. Market for COVID-19 Diagnostics, 2020-2027
    • Figure 49: Canadian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 50: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 51: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Country, 2020
    • Figure 52: Indian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 53: Australian Market for COVID-19 Diagnostics, 2020-2027
    • Figure 54: South Korean Market for COVID-19 Diagnostics, 2020-2027
    • Figure 55: Japanese Market for COVID-19 Diagnostics, 2020-2027
    • Figure 56: Chinese Market for COVID-19 Diagnostics, 2020-2027
    • Figure 57: Rest of Asia-Pacific Market for COVID-19 Diagnostics, 2020-2027
    • Figure 58: Latin American Market for COVID-19 Diagnostics, 2020-2027
    • Figure 59: Latin American Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 60: Middle Eastern and African Market for COVID-19 Diagnostics, 2020-2027
    • Figure 61: Middle Eastern and African Market Shares of COVID-19 Diagnostics, by Type, 2020
    • Figure 62: Abbott: Revenue Share, by Region, 2019
    • Figure 63: Abbott: Revenue Share, by Business Segment, 2019
    • Figure 64: Abbott: R&D Expenditure, 2015-2019
    • Figure 65: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2019
    • Figure 66: Becton, Dickinson and Co.: Revenue Share, by Region, 2019
    • Figure 67: BioMerieux SA: Revenue, by Business Segment, 2015-2017
    • Figure 68: BioMerieux SA: Revenue, by Region, 2015-2017
    • Figure 69: Bio-Rad Laboratories Inc.: Revenue, by Business Segment, 2015-2019
    • Figure 70: Bio-Rad Laboratories Inc.: Revenue, by Region, 2015-2019
    • Figure 71: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2019
    • Figure 72: Danaher Corp.: Revenue Share, by Segment, 2019
    • Figure 73: Danaher Corp.: Revenue Share, by Region, 2019
    • Figure 74: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
    • Figure 75: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
    • Figure 76: Glenmark Diagnostics Inc.: Revenue Share, by Business Segment, 2019
    • Figure 77: Hologic Inc.: Financials, 2014-2019
    • Figure 78: Hologic Inc.: Revenue Share, by Region, 2019
    • Figure 79: Hologic Inc.: Revenue Share, by Segment, 2019
    • Figure 80: Qiagen NV: Net Sales Share, by Region, 2017
    • Figure 81: Siemens Healthcare AG: Revenue Share, by Business Segment, 2019
    • Figure 82: Siemens Healthcare AG: Revenue Share, by Region, 2019
    • Figure 83: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019
目次
Product Code: MDS015A

Highlights:

The global market for COVID-19 diagnostics is valued at $60.3 billion in 2020. The market should grow from $84.4 billion in 2021 to $195.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% during 2021-2027.

The global market for COVID-19 based molecular tests should grow from $48.9 billion in 2021 to $112.0 billion by 2027, at a CAGR of 14.8% during 2021-2027.

The global market for COVID-19 based serology tests should grow from $35.5 billion in 2021 to $83.1 billion by 2027, at a CAGR of 15.2% during 2021-2027.

Report Scope:

The current report offers a detailed picture of the market for COVID-19 diagnostics.

COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs.

This report highlights the current and future market potential for COVID-19 diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as market shares for key market players.

This report details market shares for COVID-19 diagnostics based on type, technology, end-user and geography. Based on type, the market is segmented into molecular tests and serology tests segments. Based on technology, the market is segmented into reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification, clustered regularly interspaced short palindromic repeats (CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2027. Estimated values are based on diagnostics manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 56 data tables and 39 additional tables
  • An overview of the global market for COVID-19 diagnostics
  • Estimation of the market size of global COVID-19 diagnostics and analyses of global market trends, with estimated data from 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2027
  • Explanation of factors driving and restraining the growth of global COVID-19 diagnostics market
  • A look at the Case-Fatality Rate (CFR), global confirmed cases and confirmed deaths due to COVID-19 and COVID-19 clinical trial landscape
  • Information on potential targets for COVID-19 drug development such as Basigin (CD147), C-C Chemokine Receptor Type 5 (CCR5) and many more
  • Details about collaboration between organizations and governments to stop this pandemic and recent research and development activities for COVID-19
  • Market share analysis of the key companies of the industry, their strategic profiling and key competitive landscape
  • Detailed company profiles of market leading participants, including Abbott, Danaher Corp., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Pandemic Outbreaks
  • History of Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Case-Fatality Rate (CFR)
  • Global Confirmed Cases and Confirmed Deaths Due to COVID-19
  • Lessons Learned from the Past
  • Healthcare Worker Infections
  • Collaboration Between Organizations and Governments
  • Spread of the Disease

Chapter 4 COVID-19 and R&D Efforts

  • Potential Targets for COVID-19 Drug Development
  • Basigin (CD147)
  • C-C Chemokine Receptor Type 5 (CCR5)
  • Envelope Protein (E) (SARS-CoV-2; COVID-19)
  • Epithelial Sodium Channel (ENaC)
  • Histamine N-Methyltransferase (HMT)
  • Interleukin-6 Receptor Subunit α (IL-6RA)
  • Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
  • Nucleocapsid (N) (SARS-CoV-2; COVID-19)
  • Research and Development on COVID-19
  • Need to Reinvent Ventilators
  • COVID-19 Clinical Trial Landscape

Chapter 5 Economic Impact of COVID-19

  • Impact of Coronavirus on the Global Economy
  • Government Expenditures on COVID-19
  • Predictions for the Global Economy
  • Quick Recovery
  • Global Slowdown
  • Pandemic and Recession
  • Social Impact of COVID-19

Chapter 6 Impact of COVID-19 on the Healthcare Industry

  • Impact of COVID-19 on Pharma Supply Chains
  • Disruption of Clinical Trials
  • Impact on Insurance Providers
  • Impact on Health Technology Assessment
  • Threat to Healthcare Acquisitions

Chapter 7 Market Dynamics

  • Market Drivers
  • Overview
  • Increasing Number of COVID 19 Cases
  • Government and Private Funds to Support Research and Development of COVID-19 Test Kits and Vaccine
  • Rising Number of Emergency Use Authorizations (EUA) for Diagnostic Kits and Devices
  • Growing Geriatric Populations
  • Key Developments and Support by Non-medical Device/Diagnostic Companies
  • Market Restraints
  • Restrictions on Export of Diagnostic Kits
  • Accuracy of Test Results
  • Market Opportunities
  • Development of Quick, Accurate and Affordable Tests
  • Strategic R&D Initiatives

Chapter 8 Market Breakdown by Type

  • Global Market for COVID-19 Diagnostics by Type
  • Molecular Tests
  • Market Size and Forecast
  • Serology Tests
  • Market Size and Forecast

Chapter 9 Market Breakdown by Technology

  • Global Market for COVID-19 Diagnostics by Technology
  • RT-PCR
  • Market Size and Forecast
  • Isothermal Amplification
  • Market Size and Forecast
  • CRISPR
  • Market Size and Forecast
  • ELISA
  • Market Size and Forecast
  • Hybridization
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 10 Market Breakdown by End User

  • Global Market for COVID-19 Diagnostics by End User
  • Hospitals
  • Market Size and Forecast
  • Public Health Laboratories
  • Market Size and Forecast
  • Private Laboratories
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 11 Market Breakdown by Region

  • Global Market for COVID-19 Diagnostics by Region
  • Europe
  • United Kingdom
  • Spain
  • Germany
  • Italy
  • France
  • Rest of Western Europe
  • Eastern Europe
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • India
  • Australia
  • South Korea
  • Japan
  • China
  • Rest of Asia-Pacific
  • Latin America
  • Market Size and Forecast
  • Market Analysis
  • Middle East and Africa
  • Market Size and Forecast

Chapter 12 Regulatory Structure of the COVID-19 Diagnostics Industry

  • Coronavirus Treatment Acceleration Program (CTAP)
  • Clinical Trials Being Conducted During COVID-19 Pandemic
  • Drug Shortages Response
  • National Regulatory Agencies for Ongoing Clinical Trials During the COVID-19 Pandemic
  • U.S. FDA
  • Medicines and Healthcare Products Regulatory Agency (U.K.)
  • European Medicines Agency

Chapter 13 Competitive Landscape

  • Global Company Ranking Analysis
  • Insights into the Global Market for COVID 19 Diagnostics
  • Competitors
  • Mergers and Acquisitions
  • Agreements, Contracts, Collaborations and Partnerships
  • New Product Approvals

Chapter 14 Company Profiles

  • Major Diagnostics Manufacturers
  • ABBOTT
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GENMARK DIAGNOSTICS INC.
  • HOLOGIC INC.
  • QIAGEN NV
  • SIEMENS HEALTHCARE AG
  • THERMO FISHER SCIENTIFIC INC.
  • Other Prominent Companies
  • 1DROP DIAGNOSTICS
  • CEPHEID
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • PERKINELMER INC.
  • QUEST DIAGNOSTICS
  • VEREDUS LABORATORIES

Chapter 15 Appendix: Acronyms